Skip to main content

#153327

Anti-CD45 [X16]

Cat. #153327

Anti-CD45 [X16]

Cat. #: 153327

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: CD45

Class: Monoclonal

Application: FACS ; IHC ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Karen Pulford

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD45 [X16]
  • Alternate name: Leukocyte Common Antigen; Leucocyte Common Antigen; LCA; Receptor-type tyrosine-protein phosphatase C, PTPRC
  • Research fields: Cell signaling and signal transduction;Immunology
  • Clone: X16
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; IP ; WB
  • Description: CD45 (leucocyte common antigen) is a receptor-linked protein tyrosine phosphatase that is expressed on all leucocytes, and plays a crucial role in the function of these cells.
  • Immunogen: T cell Lymphoma cells
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: CD45
  • Target background: CD45 (leucocyte common antigen) is a receptor-linked protein tyrosine phosphatase that is expressed on all leucocytes, and plays a crucial role in the function of these cells.

Applications

  • Application: FACS ; IHC ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -80° C
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.